معرفی
Aleksandra Antovic is an Adjunct Senior Lecturer (Docent) at Karolinska Institutet and a Senior Consultant in Rheumatology at Karolinska University Hospital. Since 2024, she has served as the research group leader for the SLE/APS/ANCA-vasculitis group within the Department of Medicine, Solna. Her work bridges clinical rheumatology with research in autoimmune diseases, particularly focusing on vascular complications in systemic inflammatory conditions.
Dr. Antovic earned her Doctor of Philosophy from the Department of Surgical Science at Karolinska Institutet in 2004 and was awarded Docent status in 2015. She has received recognition including the Pedagogic Award at Karolinska Institutet's Department of Medicine Huddinge in 2016.
Her primary research interests center on systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and ANCA-associated vasculitis (AAV), with particular focus on thromboembolic manifestations in these conditions. Through longitudinal studies of well-characterized patient cohorts, she has identified four autoantibody-defined subgroups among SLE patients and investigates how these subgroups differ in symptoms, inflammation types, and genetics. Her work spans clinical studies, translational projects with molecular immunologists and geneticists, and patient-centered research on educational needs and perceptions.
Dr. Antovic's research has highlighted the importance of vascular complications in rheumatic diseases, expanding this research area across multiple collaborative groups. She has been awarded the Scandinavian Research Foundation/Scandinavian Journal of Rheumatology's award for successful research in rheumatology.
As an educator, she has supervised numerous PhD students both as main supervisor and co-supervisor, with projects focusing on hemostatic disturbances, pregnancy complications, and autoimmune conditions. Her current grants investigate thrombotic complications in rheumatic diseases, SLE subgrouping, and predictors of venous thromboembolism.
The SLE/APS/Vasculitis research group she leads consists of approximately 20 members including clinical researchers, postdocs, doctoral students, research nurses, and a research patient partner. The group conducts clinical research primarily on SLE, APS, and AAV, often in collaboration with molecular immunologists, geneticists, and epidemiologists.